➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Mallinckrodt
Merck
Harvard Business School
Colorcon

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

LOPERAMIDE HYDROCHLORIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Loperamide Hydrochloride patents expire, and what generic alternatives are available?

Loperamide Hydrochloride is a drug marketed by Bionpharma Inc, Mylan, Roxane, Teva, Yaopharma Co Ltd, Allied, Alpharma Us Pharms, Duramed Pharms Barr, Hi Tech Pharma, Perrigo, Watson Labs, Wockhardt Bio Ag, Perrigo R And D, Able, Aurobindo Pharma Ltd, Contract Pharmacal, L Perrigo Co, LNK, Ohm Labs, and Sun Pharm Inds Ltd. and is included in twenty-five NDAs.

The generic ingredient in LOPERAMIDE HYDROCHLORIDE is loperamide hydrochloride; simethicone. There are eleven drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the loperamide hydrochloride; simethicone profile page.

Drug patent expirations by year for LOPERAMIDE HYDROCHLORIDE
Recent Clinical Trials for LOPERAMIDE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
SOLTI Breast Cancer Research GroupPhase 2
Jiangsu HengRui Medicine Co., Ltd.Phase 1
Roche Pharma AGPhase 1

See all LOPERAMIDE HYDROCHLORIDE clinical trials

Pharmacology for LOPERAMIDE HYDROCHLORIDE
Drug ClassOpioid Agonist
Mechanism of ActionOpioid Agonists
Medical Subject Heading (MeSH) Categories for LOPERAMIDE HYDROCHLORIDE

US Patents and Regulatory Information for LOPERAMIDE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bionpharma Inc LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride CAPSULE;ORAL 021855-001 Aug 4, 2005 OTC Yes No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma Ltd LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride TABLET;ORAL 206548-001 Dec 15, 2015 OTC No No   Start Trial   Start Trial   Start Trial
Perrigo LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE loperamide hydrochloride; simethicone TABLET, CHEWABLE;ORAL 076029-001 Aug 30, 2002 OTC No Yes   Start Trial   Start Trial   Start Trial
Yaopharma Co Ltd LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride CAPSULE;ORAL 072993-001 Aug 28, 1992 DISCN No No   Start Trial   Start Trial   Start Trial
Roxane LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride CAPSULE;ORAL 073080-001 Nov 27, 1991 DISCN No No   Start Trial   Start Trial   Start Trial
Perrigo LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride SOLUTION;ORAL 073243-001 Jan 21, 1992 OTC No No   Start Trial   Start Trial   Start Trial
L Perrigo Co LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride TABLET;ORAL 075232-001 Jan 6, 2000 OTC No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Express Scripts
Colorcon
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.